[go: up one dir, main page]

FR2808687B1 - Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose - Google Patents

Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose

Info

Publication number
FR2808687B1
FR2808687B1 FR0005375A FR0005375A FR2808687B1 FR 2808687 B1 FR2808687 B1 FR 2808687B1 FR 0005375 A FR0005375 A FR 0005375A FR 0005375 A FR0005375 A FR 0005375A FR 2808687 B1 FR2808687 B1 FR 2808687B1
Authority
FR
France
Prior art keywords
apoptosis
activation
medicament containing
containing polysaccharide
polysaccharide substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0005375A
Other languages
English (en)
Other versions
FR2808687A1 (fr
Inventor
Jean Claude Yvin
Andre Patrick Arrigo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Goemar SA
Original Assignee
Laboratoires Goemar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Goemar SA filed Critical Laboratoires Goemar SA
Priority to FR0005375A priority Critical patent/FR2808687B1/fr
Priority to PCT/FR2001/001323 priority patent/WO2001080807A2/fr
Priority to CA002407504A priority patent/CA2407504A1/fr
Priority to US10/258,840 priority patent/US20030166609A1/en
Priority to AU2001256441A priority patent/AU2001256441A1/en
Priority to EP01929755A priority patent/EP1276484A2/fr
Publication of FR2808687A1 publication Critical patent/FR2808687A1/fr
Application granted granted Critical
Publication of FR2808687B1 publication Critical patent/FR2808687B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0005375A 2000-04-27 2000-04-27 Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose Expired - Fee Related FR2808687B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0005375A FR2808687B1 (fr) 2000-04-27 2000-04-27 Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose
PCT/FR2001/001323 WO2001080807A2 (fr) 2000-04-27 2001-04-27 Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose
CA002407504A CA2407504A1 (fr) 2000-04-27 2001-04-27 Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose
US10/258,840 US20030166609A1 (en) 2000-04-27 2001-04-27 Medicine containing polysacccharide substances for activating apoptosis
AU2001256441A AU2001256441A1 (en) 2000-04-27 2001-04-27 Medicine containing polysaccharide substances for activating apoptosis
EP01929755A EP1276484A2 (fr) 2000-04-27 2001-04-27 Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0005375A FR2808687B1 (fr) 2000-04-27 2000-04-27 Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose

Publications (2)

Publication Number Publication Date
FR2808687A1 FR2808687A1 (fr) 2001-11-16
FR2808687B1 true FR2808687B1 (fr) 2003-12-05

Family

ID=8849659

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0005375A Expired - Fee Related FR2808687B1 (fr) 2000-04-27 2000-04-27 Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose

Country Status (6)

Country Link
US (1) US20030166609A1 (fr)
EP (1) EP1276484A2 (fr)
AU (1) AU2001256441A1 (fr)
CA (1) CA2407504A1 (fr)
FR (1) FR2808687B1 (fr)
WO (1) WO2001080807A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906492B2 (en) 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US20080131454A1 (en) * 2006-12-05 2008-06-05 Marinomed Biotechnologie Gmbh Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
BRPI0813420B1 (pt) * 2007-06-28 2018-05-15 Basf Beauty Care Solutions France Sas Uso de uma preparação, composição, e, método cosmético de cuidado para emagrecimento
US8153611B2 (en) * 2007-06-28 2012-04-10 Basf Beauty Care Solutions France S.A.S. Use of sulfated oligosaccharides as slimming cosmetic ingredients
FR2917971B1 (fr) 2007-06-28 2009-10-23 Engelhard Lyon Soc Par Actions Composition amincissante
EA018138B1 (ru) 2007-08-24 2013-05-30 Мариномед Биотехнологи Гмбх Применение йота-каррагенана в качестве противовирусного ингредиента
EA020222B1 (ru) * 2008-07-01 2014-09-30 Мариномед Биотехнологи Гмбх Противоаллергическое средство, содержащее йота-каррагинан

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
GB9218510D0 (en) * 1992-09-01 1992-10-14 Medical Res Council Improvements in or relating to hormone antagonists
EP0664700A1 (fr) * 1992-10-13 1995-08-02 Otsuka America Pharmaceutical, Inc. Traitement de la cachexie et inhibition de l'activite de il-6
CN1174557A (zh) * 1994-12-01 1998-02-25 生化学工业株式会社 硫酸角质素寡聚糖级分及含该级分的药剂
AUPN261895A0 (en) * 1995-04-28 1995-05-18 Australian National University, The Preparation and use of sulfated oligosaccharides
US6037332A (en) * 1996-02-20 2000-03-14 Emory University Method of urinary bladder instillation
US6038332A (en) * 1997-09-05 2000-03-14 Digital Biometrics, Inc. Method and apparatus for capturing the image of a palm
FR2774289B1 (fr) * 1998-02-03 2002-05-24 Goemar Lab Sa Medicament pour le traitement des dereglements de l'apoptose

Also Published As

Publication number Publication date
AU2001256441A1 (en) 2001-11-07
US20030166609A1 (en) 2003-09-04
EP1276484A2 (fr) 2003-01-22
CA2407504A1 (fr) 2001-11-01
WO2001080807A3 (fr) 2002-04-18
FR2808687A1 (fr) 2001-11-16
WO2001080807A2 (fr) 2001-11-01

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
CY2014003I2 (el) Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
MA25823A1 (fr) Compositions pour le traitement de l'eau.
DK1052974T3 (da) Farmaceutisk sammensætning indeholdende epothilon
EE04613B1 (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
EE05020B1 (et) Glburiidi ravimkoostis
HUP0303566A3 (en) Pharmaceutical composition containing combination of fenofibrate and coenzyme q10 and its use for the treatment of endothelial dysfunction
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
MA25234A1 (fr) Vibromasseur pour le soulagement des maux et de la douleur.
FR2815541B1 (fr) Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
PL354028A1 (pl) Farmaceutyczne roztwory levosimendanuFarmaceutyczne roztwory levosimendanu
EP1165597A4 (fr) Molecules bifonctionnelles pour administration d'agents therapeutiques
FR2808687B1 (fr) Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose
MA26899A1 (fr) PREPARATIONS CONTENANT UN MEDICAMENT GLUCOCORTICOiDE POUR LE TRAITEMENT DES MALADIES BRONCHOPULMONAIRES.
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
NO20012106D0 (no) Middel for behandling av benpatobolisme
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
EP1572129A4 (fr) Derives d'amidine pour le traitement des amyloses
MA26117A1 (fr) Nouveau compose pour le traitement de l'impuissance
FR2774289B1 (fr) Medicament pour le traitement des dereglements de l'apoptose
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081231